Details for New Drug Application (NDA): 201463
✉ Email this page to a colleague
The generic ingredient in DRONABINOL is dronabinol. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dronabinol profile page.
Summary for 201463
Tradename: | DRONABINOL |
Applicant: | Lannett Co Inc |
Ingredient: | dronabinol |
Patents: | 0 |
Suppliers and Packaging for NDA: 201463
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DRONABINOL | dronabinol | CAPSULE;ORAL | 201463 | ANDA | Lannett Company, Inc. | 0527-1450 | 0527-1450-06 | 60 CAPSULE in 1 BOTTLE, PLASTIC (0527-1450-06) |
DRONABINOL | dronabinol | CAPSULE;ORAL | 201463 | ANDA | Lannett Company, Inc. | 0527-1451 | 0527-1451-06 | 60 CAPSULE in 1 BOTTLE, PLASTIC (0527-1451-06) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 2.5MG | ||||
Approval Date: | May 18, 2018 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 5MG | ||||
Approval Date: | May 18, 2018 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
Approval Date: | May 18, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription